These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21968367)

  • 1. Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
    Chou S; Marousek G; Bowlin TL
    Antimicrob Agents Chemother; 2012 Jan; 56(1):197-201. PubMed ID: 21968367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
    Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
    James SH; Price NB; Hartline CB; Lanier ER; Prichard MN
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3321-5. PubMed ID: 23650158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
    Chou S; Marousek GI
    J Virol; 2008 Jan; 82(1):246-53. PubMed ID: 17942550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
    Scott GM; Weinberg A; Rawlinson WD; Chou S
    Antimicrob Agents Chemother; 2007 Jan; 51(1):89-94. PubMed ID: 17043128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
    O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
    Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives.
    Chou S; Komazin-Meredith G; Williams JD; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(3):1809-12. PubMed ID: 24379208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus.
    Chou S; Marousek G; Li S; Weinberg A
    J Clin Virol; 2008 Sep; 43(1):107-9. PubMed ID: 18502683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
    Drew WL; Miner RC; Marousek GI; Chou S
    J Clin Virol; 2006 Oct; 37(2):124-7. PubMed ID: 16962820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
    Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
    J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
    Chou S; Ercolani RJ; Lanier ER
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3845-8. PubMed ID: 27044553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of cytomegalovirus UL54 exonuclease domain mutations on acyclovir and cidofovir susceptibility.
    Chou S
    Antiviral Res; 2021 Nov; 195():105181. PubMed ID: 34560144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.
    Chou S; Bowlin TL
    Antimicrob Agents Chemother; 2011 Jan; 55(1):382-4. PubMed ID: 21041510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy.
    Chou S
    J Clin Virol; 2011 Apr; 50(4):287-91. PubMed ID: 21295516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.
    Chou S; Ercolani RJ; Sahoo MK; Lefterova MI; Strasfeld LM; Pinsky BA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4697-702. PubMed ID: 24890586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
    Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
    J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
    Cihlar T; Fuller MD; Cherrington JM
    J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.